In short
Citicoline supplies raw materials the brain uses to build cell membranes and the signalling molecule acetylcholine. Controlled trials have found benefits for memory and attention, but it acts cumulatively over weeks rather than as an acute hit. European authorities reviewed a citicoline memory claim in 2024 and did not find the evidence sufficient to authorise it, so we present what the trials show and are explicit about that. LAYER ZERO uses 300 mg in the morning layer as a foundational cognitive ingredient.
Citicoline is one of the more studied nootropics, and also one where the honest account requires holding two things at once: real trial signals, and a regulator that has not yet been convinced.
01What citicoline is
Citicoline, also called CDP-choline, is a compound the body uses in building and maintaining brain cell membranes, and as a source of choline for acetylcholine, a neurotransmitter involved in attention and memory. It is not a stimulant. It works by supplying materials the brain draws on, which is a slower and quieter mechanism than the fast lift of a stimulant.
Definition · Nootropic
A compound taken with the aim of supporting cognitive function such as memory, attention, or mental energy. As with any category, the strength of evidence differs by compound, and citicoline sits among the better-studied ones without being a settled case.
02What the trials show
In a 12-week randomised, double-blind, placebo-controlled trial in healthy older adults, citicoline improved measures of memory compared with placebo.1 Separately, controlled work on attention and motor speed has reported improvements with citicoline supplementation.2 These are genuine, placebo-controlled signals for a cognitive ingredient, which is more than many nootropics can show.
The important qualifier comes next, and we give it its own section rather than burying it.
03It works cumulatively
Citicoline is not something you feel an hour after taking it. The trials that show benefit run for weeks, because the mechanism is the steady supply of building blocks, not an acute effect on alertness. This makes it the opposite of a stimulant, and a natural fit for a system built on baselines rather than peaks. It is taken every morning to raise a floor over time, not to produce a spike you notice on the day. We explain that distinction in peak vs. baseline.
04Why the morning, and 300 mg
As a cognitive-support ingredient without sedative properties, citicoline belongs at the start of the day, in LAYER ONE, alongside the other morning ingredients aimed at focus. LAYER ZERO uses 300 mg, a dose within the range used in the supportive human trials, placed in the morning stack as a foundational contributor rather than a headline stimulant.
05What is still uncertain
Where the regulators have not agreed
That is the difference between a claims register and a literature, worth knowing and not worth fearing. In 2024 the European Food Safety Authority evaluated a health claim linking citicoline to memory function and concluded that a cause-and-effect relationship had not been established, and the claim was not authorised.3 That is the reason we describe what individual trials found rather than stating citicoline improves memory as a fact. Some of the supportive trials are also industry-funded, and effects are modest. We include citicoline for its plausible, trial-supported role, while being clear that the regulatory standard for a claim has not been met.
06The research horizon
Citicoline's newest data extends both ends of its story. A 2023 meta-analysis in Nutrients pooled the controlled evidence on citicoline in cognitive decline and found support for benefit in impairment and prevention contexts, medicinal territory this page notes rather than borrows.4 A 2026 real-world cohort followed 100 adults with early cognitive complaints on citicoline-based supplementation for six to nine months and reported multidomain improvements in executive function, processing speed, and memory.5 The frontier is the eye: because the retina is brain tissue, citicoline is now in randomised trials as optic-nerve support in glaucoma, measured by electroretinogram.6 The nearest readout to watch is a completed 12 week randomised trial of citicoline on psychomotor vigilance in 90 healthy young adults, run in Japan, with publication pending. A compound still generating this much new work five decades after its synthesis is not a trend. It is infrastructure.
07How LAYER ZERO uses this
Citicoline is a baseline ingredient in the truest sense: quiet, cumulative, and aimed at where your cognition sits over time rather than at a moment you feel. That is exactly the logic of the system. It sits in the morning layer as long-term support, held to the same honest standard as everything else in the Library. The claim file is the regulator's; the twelve week trials are the literature's; the baseline job in the morning layer is citicoline's.
In the system
LAYER ONE is the morning layer, built for focus and resilience. Citicoline is its cumulative, foundational component, the counterpart to the faster-acting ingredients around it. To see how a day built on baselines rather than peaks maps to your own schedule, the protocol builder takes about three minutes. Build your protocol →
Sources
Next in this thread
Peak vs. baselineWhy a cumulative ingredient like citicoline fits a system built on the floor of the day, not the spike.→How we handle evidence. Every claim on this page is graded and linked to a primary source, and we say where the science is not yet settled. This page is educational and is not medical advice or a health claim about any product.